CellaVision AB
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About CellaVision AB
CellaVision AB is engaged in the business of supplying digital solutions for blood and body fluid analysis. Its solutions are based on digital image analysis technology, artificial intelligence, and information technology. The firm's product portfolio consists of CellaVision peripheral blood application, CellaVision advanced RBC application, and CellaVision remote review software. Its customers include mainly large hospital laboratories and commercial laboratories in North America, Europe and China, and Japan. The company derives the majority of its revenue from the sale of analyzers or software.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy CellaVision AB stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for CellaVision AB by name or ticker, choose the number of shares, and place your order.
The ticker symbol for CellaVision AB is CEVI:xome. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
CellaVision AB has its primary listing on NASDAQ OMX Stockholm. You can trade CellaVision AB with a Saxo account, alongside thousands of other stocks worldwide.
Yes, CellaVision AB is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include CellaVision AB as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like CellaVision AB.